These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1143690)

  • 1. [Clinical and epidemiological repercussions of bacterial resistance].
    Fortunio G; Cortronei G
    Minerva Med; 1975 Apr; 66(32):1519-30. PubMed ID: 1143690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of the most widespread bacterial infections and current trends in use of antibiotics].
    Fortunio G; Cotronei G; Viola F
    Arch Sci Med (Torino); 1977; 134(4):461-74. PubMed ID: 610693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-factors in gram-positive and gram-negative aerobic bacteria selected by antimicrobial therapy.
    Buu-Hoi A; Goldstein FW; Acar JF
    Scand J Infect Dis Suppl; 1986; 49():46-55. PubMed ID: 3547625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibiotic strategy in infections caused by resistant strains during intensive care].
    Veyssier P
    Agressologie; 1991; 32(4):225-9. PubMed ID: 1957964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing epidemiology of resistance.
    Hawkey PM; Jones AM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i3-10. PubMed ID: 19675017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic therapy: progress and development of resistance].
    Adam D
    Internist (Berl); 2006 Jul; 47(7):758-63. PubMed ID: 16703381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global resistance trends and the potential impact on empirical therapy.
    Isturiz R
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S201-6. PubMed ID: 19134520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004].
    Mroczkowski P; Lauf H; Lippert H; König W; Meyer F
    Zentralbl Chir; 2009 Jun; 134(3):226-30. PubMed ID: 19536716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of resistance in gram-negative bacilli during beta-lactam therapy: a challenge for the future.
    Pechère JC
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S17-23. PubMed ID: 2693106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors of resistance to chemotherapeutic agents (R factors) observed in strains of enterobacteria isolated in southern Italy and Sicily].
    Giammanco G; Natoli D; Carmeni A; Giacalone F
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1794-7. PubMed ID: 5733071
    [No Abstract]   [Full Text] [Related]  

  • 16. Has the era of untreatable infections arrived?
    Livermore DM
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i29-36. PubMed ID: 19675016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance: implications for managing respiratory failure.
    Chenoweth C; Lynch JP
    Curr Opin Pulm Med; 1997 Mar; 3(2):159-69. PubMed ID: 9193863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [60 years' of antibiotics--resistance: a time bomb for the third millenium].
    Blahová J; Králiková K; Krcméry V
    Cas Lek Cesk; 2000 Oct; 139(20):615-9. PubMed ID: 11192755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Means of bacterial resistance].
    Moreillon P
    Rev Med Suisse Romande; 2000 Aug; 120(8):641-50. PubMed ID: 11028184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.